ProLynx Inc.
PrivateLast Round
Series A
Dec 11, 2025
Total Funding Raised
$72.65M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
ProLynx Inc. is a biotechnology company developing a portfolio of ultra-long-acting medicines for obesity and related metabolic diseases using its proprietary half-life extension technology platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ProLynx Inc. Comparables
Compare ProLynx Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Serina Therapeutics Inc | 79% | |
| InnoCore Pharmaceuticals | 79% | |
| Johnson & Johnson | 76% | |
ProLynx Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 11, 2025 | ||||
| Seed | Sep 10, 2020 | ||||
| Grant | Jul 7, 2020 | ||||
| Debt | Apr 14, 2020 | ||||
| Grant | Nov 1, 2018 | ||||
Grant | Sep 25, 2017 |
ProLynx Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| OrbiMed | Series A |
| 5AM Ventures | Series A |
| Monograph Capital | Series A |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Grew 15% QoQ, from 33 to 38 employees.
- Jun 19, 2026
Monthly visitors increased 1674% MoM, reaching 1.2K.
ProLynx Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ProLynx Inc.'s valuation, stock price, and market status.